Bacterial vaccines play a crucial role in preventing and controlling infectious diseases caused by bacteria. Unlike viral infections, bacterial diseases are often targeted through vaccines that stimulate the immune system to recognize and defend against specific bacterial pathogens. There are two main types of bacterial vaccines: polysaccharide vaccines and protein-conjugate vaccines. Polysaccharide vaccines target the outer coating of bacteria and are effective against diseases such as pneumococcal pneumonia and meningococcal meningitis. Protein-conjugate vaccines, on the other hand, combine bacterial proteins with carrier molecules to enhance the immune response. Examples include the Haemophilus influenzae type b (Hib) vaccine and the diphtheria-tetanus-pertussis (DTP) vaccine. The development and widespread use of bacterial vaccines have contributed significantly to the decline in morbidity and mortality associated with bacterial infections. Vaccination programs have successfully controlled diseases like tetanus, diphtheria, and pertussis, preventing their resurgence. Additionally, advancements in vaccine technology continue to improve the effectiveness, safety, and accessibility of bacterial vaccines. Ongoing research aims to expand the range of bacterial diseases preventable through vaccination, addressing emerging threats and enhancing global immunization efforts.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain